These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17384090)

  • 21. [Revascularisation of unprotected left main coronary artery disease: an update].
    Eltchaninoff H; Tron C; Brunet D; Baala B; Cribier A
    Arch Mal Coeur Vaiss; 2007 Mar; 100(3):207-11. PubMed ID: 17536424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stenting or coronary artery bypass surgery for triple vessel disease?].
    Sleilaty G; Achouh P; Fabiani JN
    Ann Cardiol Angeiol (Paris); 2009 Apr; 58(2):104-12. PubMed ID: 18930176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of stable angina. Coronary angioplasty versus medical treatment].
    Spaulding C; Richard P; Belaouchi F; Monsegu J; Py A; Cador R; Weber S
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1603-7. PubMed ID: 10598242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Refractory vasospastic angina causing myocardial infarction and VF arrest requiring combined medical, electrophysiological, percutaneous and surgical intervention--a case report.
    Nishtar SS; Ali T; Azeem T; Shaukat N; Gershlick A
    Int J Cardiol; 2007 Jun; 119(1):e4-7. PubMed ID: 17448550
    [No Abstract]   [Full Text] [Related]  

  • 25. Residual high-grade angina after enhanced external counterpulsation therapy.
    McCullough PA; Henry TD; Kennard ED; Kelsey SF; Michaels AD;
    Cardiovasc Revasc Med; 2007; 8(3):161-5. PubMed ID: 17765644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Invasive treatment of angina pectoris. A need for re-thinking?].
    Høilund-Carlsen PF; Amtorp O
    Ugeskr Laeger; 2000 Jun; 162(24):3437-42. PubMed ID: 10918825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
    Chocron S; Baillot R; Rouleau JL; Warnica WJ; Block P; Johnstone D; Myers MG; Calciu CD; Nozza A; Martineau P; van Gilst WH;
    Eur Heart J; 2008 Mar; 29(5):673-9. PubMed ID: 18285358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of off-pump coronary artery bypass grafting with percutaneous coronary intervention versus drug-eluting stents for three-vessel coronary artery disease.
    Yi G; Youn YN; Yoo KJ; Hong YS
    Ann Thorac Surg; 2008 Nov; 86(5):1438-43. PubMed ID: 19049727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent and resistant angina: is the metabolic approach an appropriate answer?
    Marzilli M
    Coron Artery Dis; 2004 May; 15 Suppl 1():S23-7. PubMed ID: 15179125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
    Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of health-related quality of life after coronary revascularization.
    Bonaros N; Schachner T; Ohlinger A; Friedrich G; Laufer G; Bonatti J
    Heart Surg Forum; 2005; 8(5):E380-5. PubMed ID: 16174598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple extensive coronary artery stenting: does it compromise future surgical revascularization?
    Al-Attar N; Nataf P
    Curr Opin Cardiol; 2007 Nov; 22(6):529-33. PubMed ID: 17921740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.
    Kirtane AJ; Chieffo A; Magni V; Mehran R; Colombo A; Moses JW
    Minerva Cardioangiol; 2008 Feb; 56(1):43-53. PubMed ID: 18432168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of percutaneous coronary interventions in early postcoronary artery bypass graft occlusion or stenosis.
    Abdulmalik A; Arabi A; Alroaini A; Rosman H; Lalonde T
    J Interv Cardiol; 2007 Jun; 20(3):204-8. PubMed ID: 17524112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revascularization for ischaemic cardiomyopathy.
    Shanmugam G; Légaré JF
    Curr Opin Cardiol; 2008 Mar; 23(2):148-52. PubMed ID: 18303528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty.
    Vignali L; Talanas G; Menozzi A; Cattabiani MA; Solinas E; Aurier E; Ardissino D
    Minerva Cardioangiol; 2008 Feb; 56(1):1-11. PubMed ID: 18432163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the clinical use of transmyocardial laser revascularization.
    Bridges CR
    Semin Thorac Cardiovasc Surg; 2006; 18(1):68-73. PubMed ID: 16766257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.